Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare - Alcanza Clinical Research

Create a Profile

This field is for validation purposes and should be left unchanged.
I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

Create a Profile

This field is for validation purposes and should be left unchanged.
I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

Get In Touch Mobile

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
I accept digital forms of communication(Required)

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location
Back
Date Published: 06/23/2026

Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare

Acquisition expands Alcanza’s site network, adding five locations across Tennessee and Florida

Alcanza Clinical Research announced the acquisition of CNS Healthcare, an established independent clinical research network with a three-decade legacy of advancing medical science and patient care. Founded in 1996, CNS Healthcare has completed thousands of clinical trials across key therapeutic areas, including neuroscience and behavioral health. With five locations across Memphis, TN, Jacksonville and Orlando, FL, and a mobile clinical trial vehicle, CNS Healthcare has been a preferred research network for both community participants and global sponsors, recognized for high-quality clinical data and a patient-centric environment.

CNS Healthcare has built a strong reputation for high-quality clinical research, supported by an experienced team of Principal Investigators and many other research professionals. Under the leadership of CEO Dan Kearney, the organization has expanded its capabilities and industry partnerships with a 30-year track record of consistent site performance and trial delivery.

“We are truly excited to join the Alcanza team. Their commitment to inclusiveness in all that they do ties into how we, at CNS Healthcare, have operated for over 30 years. The team at Alcanza has been wonderful to work with and I look forward to seeing the value our combined capabilities will deliver,” said Dan Kearney, CEO of CNS Healthcare.

“Working alongside high-performing clinical research organizations continues to be a key focus for Alcanza. We are pleased to welcome CNS Healthcare and its outstanding team to our growing site network,” said Carlos Orantes, CEO of Alcanza Clinical Research.

The addition of CNS Healthcare further strengthens Alcanza’s clinical trial site network of high-performing research sites and expands its multispecialty therapeutic capabilities. With a shared commitment to quality study execution and inclusive patient engagement, the integration of Alcanza and CNS Healthcare enhances the organization’s capacity to deliver on its “Clinical Research for All™” mission and significantly broadens its site access throughout diverse communities.

Back

Ready to be part of healthcare history? Find the right clinical trial for you.

Get In Touch

This field is for validation purposes and should be left unchanged.
I accept digital forms of communication(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
Accessibility Adjustment

Color Adjustment

Orientation Adjustment

Font Size

 

Line height